US2886574A - Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide - Google Patents

Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide Download PDF

Info

Publication number
US2886574A
US2886574A US622805A US62280556A US2886574A US 2886574 A US2886574 A US 2886574A US 622805 A US622805 A US 622805A US 62280556 A US62280556 A US 62280556A US 2886574 A US2886574 A US 2886574A
Authority
US
United States
Prior art keywords
dimethyl
diphenyl
pyrrolidinobutyramide
quaternary ammonium
ammonium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US622805A
Inventor
Brooke D Aspergren
Robert B Moffett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to US622805A priority Critical patent/US2886574A/en
Application granted granted Critical
Publication of US2886574A publication Critical patent/US2886574A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Definitions

  • the quaternary ammonium salts of the present invention possess excellent anticholinergic activity (i.e., antispas'modic and antisecretory activity). This is in contrast to the combination of properties shown by quaternary ammonium salts of closely related unsubstituted amides (i.e., primary amides) which lack the 4,4-dimethyl side chain.
  • the data given in Table I are illustrative of the differentiating effects noted above.
  • the antispasmodic index was determined by intravenous administration to Thiry-" Vella dogs and equated to atropine equals 1.0 (low values mean low activity).
  • the antisecretory activity was determined intravenously in rats and is given as the ED in mg./kg.the effective dose necessary to reduce gastric secretion by the percentage indicated in the table.
  • the compounds of the present invention can be pre'' pared by reacting diphenylacetonitrile with 2-methyl-2- pyrrolidinopropyl chloride in the presence of an alkali metal amide, advantageously lithium amide, to produce 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyronitrile free base.
  • This free base is hydrolyzed to produce 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base according to the procedure of Cheney et al., J. Org. Chem. 17, 771 (1952).
  • the latter free base (amide) can be purified by conversion to an acid addition salt such as the hydrochloride, sulfate, hydrobromide, phosphate, lactate, acetate, citrate, and the like, and the acid addition salt can be reconverted to the purified free base.
  • an acid addition salt such as the hydrochloride, sulfate, hydrobromide, phosphate, lactate, acetate, citrate, and the like
  • the desired 2,2-diphenyl-4,4-dirnethyl -4- pyrrolidinobutyramide lower-alkyl quaternary ammonium salts are thereupon produced by reacting the free base in an inert solvent such as methyl ethyl ketone or benzene with a quaternary ammonium salt-producing compound such as methyl chloride, methyl iodide, ethyl bromide, methyl bromide, methyl p-toluenesulfonate, butyl iodide, ethyl sulfate, ethyl iodide, and the like.
  • an inert solvent such as methyl ethyl ketone or benzene
  • a quaternary ammonium salt-producing compound such as methyl chloride, methyl iodide, ethyl bromide, methyl bromide, methyl p-toluenesul
  • the starting 2-methyl-2pyrrolidinopropyl chloride can be readily prepared from its hydrochloride which in turn can be prepared by reacting 2-rnethyl-2-pyrrolidinopropanol [Moifeth J. Org. Chem. 14, 862 (1949)] with gaseous hydrogen chloride and thionyl chloride.
  • Example.-Pre aration of 2,2-diphnyl-4,4 dime1hyl-4 pyrrolidir'zobulyramide methobromide A. 2-METHYL-2 ⁇ XBRQLIDINOP-BQPYL clarion-Inn HYDROCHLORIDE I Hydrogen chloride gas was passed into a solution of 104 grams (0.728 mole) of Z-methyI-Z-pyrro1idinopro panol (Molietnsupra) in 500 milliliters of benzene with stirring and cooling by an ice bath until the solution tested strongly acidic. While being cooled by the ice bath, 65 milliliters of thionyl chloride was slowly added with stirring. The mixture was then gently heated under:
  • the acid extract was washed with ether, made alkaline by adding 250 milliliters of twenty percent sodium hydroxide solution, and the mixture was extracted with 500 milliliters of benzene. After drying over anhydrous sodium sulfate the benzene was removed by distillation under reduced pressure, and the dark, viscous residue was distilled under vacuum.
  • the product, 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyronitrile free base weighed 140 grams; it had a boiling point of 174 to 176 degrees centigrade at 0.03 millimeter of mercury and 11 1.5681.
  • Purified 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base can be produced by mixing 2,2-diphenyl- 4,4-dimethyl-4-pyrrolidinobutyramide hydrochloride with an excess of aqueous sodium hydroxide solution, extracting the mixture with benzene, drying the benzene solution with an hydrous sodium sulfate, separating the benzene solution by decantation, and removing the benzene by distillation.

Description

United States Patent QUATERNARY AMMONIUM SALTS 0F 2,2-DI- PHENYL 4,4 DIMETHYL 4 PYRROLI- DINO-BUTYRAMIDE Brooke l Aspergren and Robert B. Molfett, Kalamazoo,
Mich, assignors to The Upjohn Company, Kalamazoo, Mich, a corporation of Michigan No Drawing. Application November 19, 1956 Serial No. 622,805
5 Claims. C1. 260-4263 trile free base, 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramid'e free base, and 2,2-diphenyl-4,4-dimethyl-4- pyrrolidinobutyramide acid addition salts are useful intermediates for the preparation of the pharmacologically active 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide lower-alkyl quaternary ammonium salts.
The quaternary ammonium salts of the present invention possess excellent anticholinergic activity (i.e., antispas'modic and antisecretory activity). This is in contrast to the combination of properties shown by quaternary ammonium salts of closely related unsubstituted amides (i.e., primary amides) which lack the 4,4-dimethyl side chain. For example, some related compounds which lack the 4,4-dimethyl side chain show poor antispasmodic activity combined with mediocre antisecretory activity while others show poor antispasmodic activity TABLE I Anticholinergic Activity Compound I Anti- Antispasmodic secretory Index Activity 0 Br- /PJNH 3.0 s iopggcenkat C CH; g g I 6 CH,(|3-N CH l Related Compounds A. (if Br- C-NH; 1.0 50 percent at \C/ 0.2 mgJkg.
41 CHzCHr-N B. O I- t --NH; 0.08 50 pgrcenfkat 5. m. C CH; g g CH1CHN CH3 CH combined with poor antisecretory activity. Thus the quaternary ammonium salts of the present invention are desirable where excellent anticholinergic activity is desired.
The data given in Table I are illustrative of the differentiating effects noted above. The antispasmodic index was determined by intravenous administration to Thiry-" Vella dogs and equated to atropine equals 1.0 (low values mean low activity). The antisecretory activity was determined intravenously in rats and is given as the ED in mg./kg.the effective dose necessary to reduce gastric secretion by the percentage indicated in the table.
The data in Table I show that 2,2-diphenyl-4,4-dirneth- 'yl-4-pyrrolidinobutyramide methobromide possesses excel lent anticholinergic activity which would not be expect ed from the properties of closely related compounds. The importance of the 4,4-dimethyl side chain is clearly evident from the fact that compound B which contains a 4-methyl side chain and compound A which contains no side chain are clearly inferior antispasmodic agents. Compound B in addition shows poor antisecretory activity'. Thus the quaternary ammonium salts of the present invention are particularly desirable where strong anti cholinergic activity is desired.
The compounds of the present invention can be pre'' pared by reacting diphenylacetonitrile with 2-methyl-2- pyrrolidinopropyl chloride in the presence of an alkali metal amide, advantageously lithium amide, to produce 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyronitrile free base. This free base is hydrolyzed to produce 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base according to the procedure of Cheney et al., J. Org. Chem. 17, 771 (1952). The latter free base (amide) can be purified by conversion to an acid addition salt such as the hydrochloride, sulfate, hydrobromide, phosphate, lactate, acetate, citrate, and the like, and the acid addition salt can be reconverted to the purified free base. The desired 2,2-diphenyl-4,4-dirnethyl -4- pyrrolidinobutyramide lower-alkyl quaternary ammonium salts are thereupon produced by reacting the free base in an inert solvent such as methyl ethyl ketone or benzene with a quaternary ammonium salt-producing compound such as methyl chloride, methyl iodide, ethyl bromide, methyl bromide, methyl p-toluenesulfonate, butyl iodide, ethyl sulfate, ethyl iodide, and the like. The starting 2-methyl-2pyrrolidinopropyl chloride can be readily prepared from its hydrochloride which in turn can be prepared by reacting 2-rnethyl-2-pyrrolidinopropanol [Moifeth J. Org. Chem. 14, 862 (1949)] with gaseous hydrogen chloride and thionyl chloride.
The following example is illustrative of the process and products of the present invention, but is not to be construed as limiting.
Example.-Pre aration of 2,2-diphnyl-4,4 dime1hyl-4 pyrrolidir'zobulyramide methobromide A. 2-METHYL-2{{XBRQLIDINOP-BQPYL clarion-Inn HYDROCHLORIDE I Hydrogen chloride gas was passed into a solution of 104 grams (0.728 mole) of Z-methyI-Z-pyrro1idinopro panol (Molietnsupra) in 500 milliliters of benzene with stirring and cooling by an ice bath until the solution tested strongly acidic. While being cooled by the ice bath, 65 milliliters of thionyl chloride was slowly added with stirring. The mixture was then gently heated under:
reflux for two hours during which sulfur dioxide and hydrogen chloride were evolved. Part of the solvent was removed by distillation under reduced pressure whereupon the product, 2-methyl-2-pyrrolidinopropyl chloride hydrochloride, crystallized. The product was collected, washed with benzene and ether, dried, and recrystallized from a. mixture of ethanol and ethyl acetate. The yield was 138 grams and the product, 2-methyl-2-pyrrolidinopropyl chloride hydrochloride, had a melting point of 145 to 147 degrees centigrade.
Analysis.Calculated for 'C H C1 N: C, 48.49; H, 8.65; N, 7.07; Cl, 35.79. Found: C, 48.79; H, 8.74; N, 6.78; Cl, 35.58.
B. 2,2-DIPHENYL-4,4-DIMETHYL-4'PYRROLIDINO- BUTYRONITRILE FREE BASE In a three liter, 3-necked flask equipped with stirrer, reflux condenser, and dropping funnel 127.5 grams (0.66 mole) of diphenylacetonitrile was added to a slurry of 17.5 grams (0.76 mole) of lithium amide in one liter of toluene and the mixture was heated under reflux for four hours. Then 130 grams (0.66 mole) of Z-methyl- 2-pyrrolidinopropyl chloride hydrochloride was converted to the free base by treatment with fifty percent sodium hydroxide solution, the free base was extracted with 500 milliliters of toluene and the toluene extract was dried over potassium carbonate. The dried toluene extract was slowly added to the aforesaid slurry. After heating under reflux for eighteen hours, the mixture was cooled, washed with 500 milliliters of water, and then extracted with 500 milliliters of six percent hydrochloric acid. The acid extract was washed with ether, made alkaline by adding 250 milliliters of twenty percent sodium hydroxide solution, and the mixture was extracted with 500 milliliters of benzene. After drying over anhydrous sodium sulfate the benzene was removed by distillation under reduced pressure, and the dark, viscous residue was distilled under vacuum. The product, 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyronitrile free base, weighed 140 grams; it had a boiling point of 174 to 176 degrees centigrade at 0.03 millimeter of mercury and 11 1.5681.
Analysis-Calculated for C H N C, 82.97; H, 8.23; N, 8.80. Found: C, 82.23; H, 7.99; N, 9.46.
C. 2,.Z-DIPHENYL-4,4-DIMETHYLA-PYRROLIDINO- BUTYRAMIDE FREE BASE A solution of 90 milliliters of 98 percent sulfuric acid and nine milliliters of water was added to fifty grams (0.157 mole) of 2,2diphenyl-4,4-dimethyl-4- pyrrolidinobutyronitrile free base, Part B, in a 500-milliliter, 3- necked flask equipped with stirrer and reflux condenser and the mixture was heated on a steam bath for sixteen hours. The viscous solution was poured over cracked ice and made basic by the addition of 800 milliliters of concentrated ammonium hydroxide. The oil was extracted with benzene, the benzene solution was dried over anhydrous sodium sulfate, and the benzene was distilled under reduced pressure to produce 2,2-diphenyl-4,4- dimethyl-4-pyrrolidinobutyramide free base as an oil.
D. 2,2-DIPHENYL'4,4-DIMETHYL-l-PYRROLIDINO- BUTYRAMIDE HYDROCHLORIDE The 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base was dissolved in ethyl acetate and a slight excess of ethanolic hydrogen hydrochloride added to precipitate an oily product which slowly solidified. The solid was recrystallized from an isopropanol-methanol mixture to yield 35 grams of 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide hydrochloride which melted at 220 to 224 degrees centigrade.
Analysis.-Calculated for C H ClN O: C, 70.85; H, 7.84; N, 7.51; CI, 9.51. Found: C, 71.62; H, 7.70; N, 7.59; CI, 9.65.
Following the procedure of Part D, above other acid addition salts such as 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide sulfate, 2,2-diphenyl-4,4-dimethyl-4- pyrrolidinobutyramide hydrobromide, 2,2-diphenyl-4,4-
dimethyl-4-pyrrolidinobutyramide acetate, 2,2-diphenyl- 4,4 dimethyl 4 pyrrolidinobutyramide citrate, 2,2- diphenyl-4,4-dimethyl-4pyrrolidinobutyramide phosphate, 2,2-diphenyl-4,4-dimethyl-4pyrrolidinobutyramide lactate, and the like, can be produced by substituting the corresponding acid for hydrogen chloride.
Purified 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base can be produced by mixing 2,2-diphenyl- 4,4-dimethyl-4-pyrrolidinobutyramide hydrochloride with an excess of aqueous sodium hydroxide solution, extracting the mixture with benzene, drying the benzene solution with an hydrous sodium sulfate, separating the benzene solution by decantation, and removing the benzene by distillation.
E. 2,2-DIPHENYL-4,4-DIMETHYL-4-PYRROLIDINO- BUTYRAMIDE METHOBROMIDE Twenty grams (0.21 mole) of methyl bromide was added to a solution of 6.5 grams (0.019 mole) of 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide free base in milliliters of methyl ethyl ketone in a 500-milliliter, single-necked, round-bottomed flask and the mixture kept stoppered for 48 hours at about 25 degrees centigrade. The mixture was filtered and the recovered crystals were recrystallized from ethanol to yield 2,2-diphenyl-4,4-dimethyl 4 pyrrolidinobutyramide methobromide which melted at 167 to 168 degrees centigrade.
Analysis.Calculated for C H BrN- O: C, 64.03; H, 7.24; N, 6.49; Br, 18.52. Found: C, 63.87; H, 7.24; N, 6.24; Br, 18.73.
Following the procedure of Part E, above, other loweralkyl quaternary ammonium salts such as 2,2-diphenyl- 4,4-dimethyl-4pyrrolidinobutyramide ethobromide, 2,2- diphenyl-4,4-dimethyl 4 pyrrolidinobutyramide methochloride, 2,2 diphenyl-4,4-dimethy1-4-pyrrolidinobutyramide ethosulfate, 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide methiodide, 2,2-diphenyl-4,4-dimethyl- 4-pyrrolidinobutyramide ethiodide, 2,2-diphenyl-4,4- dimethyl 4 pyrrolidinobutyramide methyl p-toluenesulfonate, 2,2-diphenyl-4,4-dimethyl-4-pyrrolidinobutyramide butyl iodide, and the like can be produced by substituting the corresponding lower-alkyl quaternary ammonium saltproducing compound for methyl bromide.
It is to be understood that the invention is not to be limited to the exact details of operation or exact compounds shown and described, as obvious modifications and equivalents will be apparent to one skilled in the art, and the invention is therefore to be limited only by the scope of the appended claims.
We claim:
1. 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide free base.
2. 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide acid addition salts.
3. 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide hydrochloride.
4. 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide lower-alkyl quaternary ammonium salts.
5. 2,2 diphenyl 4,4 dimethyl 4 pyrrolidinobutyramide methobromide.
Cheney et al.: J. Org. Chem., pp. 770-777, vol. 17, January-June 1952.

Claims (1)

  1. 4. 2,2 - DIPHENYL - 4,4 - DIMETHYL - 4 - PYRROLIDINOBUTYRAMIDE LOWER-ALKYL QUATERNARY AMMONIUM SALTS.
US622805A 1956-11-19 1956-11-19 Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide Expired - Lifetime US2886574A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US622805A US2886574A (en) 1956-11-19 1956-11-19 Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US622805A US2886574A (en) 1956-11-19 1956-11-19 Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide

Publications (1)

Publication Number Publication Date
US2886574A true US2886574A (en) 1959-05-12

Family

ID=24495580

Family Applications (1)

Application Number Title Priority Date Filing Date
US622805A Expired - Lifetime US2886574A (en) 1956-11-19 1956-11-19 Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide

Country Status (1)

Country Link
US (1) US2886574A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121091A (en) * 1960-03-03 1964-02-11 Nalco Chemical Co Quaternary imidazolium and imidazolinium bisulfites
US20070105831A1 (en) * 2005-09-21 2007-05-10 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2782206A (en) * 1953-10-21 1957-02-19 Upjohn Co 2, 2-dimethyl-alpha, alpha-diphenyl-1-pyrrolidene-alkanoamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2782206A (en) * 1953-10-21 1957-02-19 Upjohn Co 2, 2-dimethyl-alpha, alpha-diphenyl-1-pyrrolidene-alkanoamides

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121091A (en) * 1960-03-03 1964-02-11 Nalco Chemical Co Quaternary imidazolium and imidazolinium bisulfites
US20070105831A1 (en) * 2005-09-21 2007-05-10 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists
US20100029720A1 (en) * 2005-09-21 2010-02-04 Paul Alan Glossop Carboxamide Derivatives As Muscarinic Receptor Antagonists
US7772223B2 (en) 2005-09-21 2010-08-10 Pfizer Inc. Carboxamide derivatives as muscarinic receptor antagonists
US8268881B2 (en) 2005-09-21 2012-09-18 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists
US8486992B2 (en) 2005-09-21 2013-07-16 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists

Similar Documents

Publication Publication Date Title
DE2461861A1 (en) 8-HYDROXYCARBOSTYRIL DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS
HU193161B (en) Process for preparing new n-alkyl-norscopines
US2831027A (en) Isocamphane compounds and processes for preparing the same
DE2461604A1 (en) 8-HYDROXY-3,4-DIHYDROCARBOSTYRIL DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS
US2692285A (en) Di-sec-alkyl-dialkylammonium salts and processes for preparing the same
JPS5919536B2 (en) Method for producing 5-aroyl-1-lower alkylpyrrole-2-acetic acid derivative
US2886574A (en) Quaternary ammonium salts of 2, 2-diphenyl-4, 4-dimethyl-4-pyrrolidino-butyramide
AT200578B (en) Process for the preparation of new N-aminoalkyl derivatives of azepines
US3078275A (en) N, n-disubstituted-alpha-(tertiaryaminoalkyl)-alpha, alpha-diphenylacetamides
US2997468A (en) Preparation of phenothiazines
US2933532A (en) Substituted 1-phenyl-2-hydrazino-propanes
US2824111A (en) Pyrrolidines
US3101340A (en) 4-tertiary-butyl-, 4-diphenylmethyl-, and 4-diphenylhydroxymethyl - piperidinopropionitriles
US2528940A (en) Pyrrolidylethyl indole compounds
US2980693A (en) Methods for producing same
US2749346A (en) Tetrahydropyridine compounds
US2586370A (en) Nu-dimethylaminoethyl-9-methylacridan and acid addition salts thereof
US2895957A (en) omega(2,6-dimethyl piperidine-1)alpha,alpha-diphenyl butyramides
CH657848A5 (en) 3,3-DIALKYL AND 3,3-ALKYLENE INDOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.
JPS6126992B2 (en)
US2759943A (en) Derivatives of 2-n-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines
US3006925A (en) J-pyrrolidyl ethanols
US2980683A (en) Process for preparing beta-substitutedethyl piperazines
Weston et al. Antispasmodics. Derivatives of 3-Phenyl-2-benzofuranone1
DE2431201A1 (en) 4-ARYLDECAHYDRO-1H-PYRROLO SQUARE BRACKET ON 3,4 SQUARE BRACKET FOR QUINOLINE DERIVATIVES, METHOD OF THEIR MANUFACTURING AND MEDICINAL PRODUCTS